Antimicrobial resistance research, funding and incentives – get updates at SMi event in London

SMi reports: Antimicrobial resistance was predicted by Alexander Fleming in his Nobel lecture (1945). Since that warning, measures have been taken in acknowledgement of the threat of AMR, but tackling this issue is still an ongoing battle. On the global scale WHO has been the most instrumental body to take action. SMi Group is proud to be part of the fight with the Superbugs & Superdrugs Conference. Now in its 20th year, the event has firmly become established as the industry's premier platform for updates on antimicrobial resistance research, funding and incentives.

Conference is taking place in London on 19 - 20 March. To join and be a part of the global force head on to Superbugs & Superdrugs website to book your attendance http://www.superbugssuperdrugs.com/openpr

PROGRAMME HIGHLIGHTS:

Analyse the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR
• Jean-Pierre Paccaud, Director of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi) - Day 1, 9:15
• Steve Holden, Medical Adviser, MSD - Day 1, 10:35

Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress
• Conrad Lichtenstein, CSO, Nemesis bioscience - Day 1, 12:15
• David Brown, Managing Director and Founder, Alchemy Biomedical Consulting - Day 1, 12:55
• Learn about regulatory pathways for the registration of new antimicrobial agents:
• Mair Powell, Senior clinical assessor, MHRA - Day 2, 9:50

Evaluate the latest incentives and funding solutions to spur drug discovery:
• Mark Albrecht, Health Scientist, HHS/ASPR/BARDA - Day 1, 9:55
• Adrian Towse, Director, Office of Health Economics - Day 2, 10:30

Explore the latest novel alternatives to antibiotics currently in development:
• Cara Cassino, Chief Medical Officer, ContraFect - Day 2, 15:10
• Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS Inc - Day 2, 16:20
• Ian Henderson , Professor of Microbial Biology, University Of Birmingham - Day 2, 17:00

View the programme, speaker line-up, and book to attend at http://www.superbugssuperdrugs.com/openpr

Superbugs & Superdrugs Team look forward to welcoming you next week to what is shaping up to be another successful show!

Contact:
+44 (0)20 7827 6000
events@smi-online.co.uk

STAY CONNECTED
LinkedIn – search 'SMi Pharma'
Twitter - @SMIpharm #smibugs

-------------------------------------------------------------------------------------------
Superbugs & Superdrugs Conference | 19 - 20 March 2018 | London, UK
http://www.superbugssuperdrugs.com/openpr
-------------------------------------------------------------------------------------------

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.

1 Westminster Bridge Road

This release was published on openPR.